metastatic prostate cancer - interpreting negative trial results
Published 9 years ago • 537 plays • Length 19:51Download video MP4
Download video MP3
Similar videos
-
2:17
custirsen shows no survival benefit in metastatic prostate cancer
-
22:36
key developments in non-metastatic & metastatic hormone-sensitive prostate cancer
-
6:48
docetaxel with androgen deprivation therapy combo in hormone-naïve metastatic prostate cancer
-
1:57
stampede: radiotherapy for men with newly diagnosed metastatic prostate cancer
-
25:53
developments in metastatic hormone-sensitive prostate cancer
-
5:00
phase iii results of prospect study for metastatic, castration-resistant prostate cancer
-
9:01
prostate cancer updates: titan and enzamet
-
4:49
survival results from stampede, radiotherapy for prostate cancer
-
4:06
combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer
-
6:10
emerging management of metastatic castration-sensitive prostate cancer: front-line chemotherapy ...
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
-
15:19
latest developments in metastatic prostate cancer from esmo 2019
-
1:18
results of the latitude trial in high-risk metastatic hormone-naive prostate cancer
-
39:02
systemic therapies for the treatment of advanced prostate cancer
-
10:55
the impact of local treatment in patients with newly diagnosed metastatic prostate cancer
-
3:01
about advanced (metastatic) prostate cancer
-
6:40
updated overall survival outcomes in enzamet (anzup 1304)
-
28:26
key developments in prostate cancer
-
1:55
arches trial overview: adt plus enzalutamide for metastatic hormone-sensitive prostate cancer